BIIB 021
Chemical Name: 6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-9H-purin-2-amine
Purity: ≥98%
Biological Activity
BIIB 021 is a selective, Hsp90 competitive inhibitor (Ki = 1.7 nM). Displays no significant activity at a range of ATP-binding kinases or Na+K+ ATPase. Induces degradation of HER-2 in vitro (EC50 = 38 nM in MCF-7 cells). Inhibits growth and promotes cell death in a variety of human tumor cells. Orally bioavailable.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
Lundgren et al.
Mol.Cancer Ther., 2009;8:921 -
BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy.
Yin et al.
Int.J.Cancer, 2010;126:1216
Product Datasheets
Citation for BIIB 021
The citations listed below are publications that use Tocris products. Selected citations for BIIB 021 include:
1 Citation: Showing 1 - 1
-
Inhibition of the NLRP3 inflammasome by HSP90 inhibitors.
Authors: Catherine B Et al.
Immunology 2021;162:84-91
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for BIIB 021
There are currently no reviews for this product. Be the first to review BIIB 021 and earn rewards!
Have you used BIIB 021?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
